“We have the potential to deliver a best-in-class therapy for DM1 patients with a broad range of clinical benefits. Additionally, we are excited about the emerging, highly differentiated profile of DYNE-251 for Duchenne muscular dystrophy which is the first exon 51 skipping treatment candi...
A comparative study introduced another tooth-borne expander; the two-arm Hyrax, with improvement of the dental anchorage including anterior extension of the arms bilaterally and contour of the palatal surfaces of the premolars [14]. It has been demonstrated that the two-arm Hyrax provokes less s...
However, since it has no side effects, dental clinics that already use PBMT may find it useful for relieving pain in patients starting RME therapy. With regard to pharmacological pain management, in some included studies the use of analgesic and/or anti-inflammatory drugs during the observation ...